SAM
Simplify Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $553K | Sell |
15,210
-1,690
| -10% | -$61.4K | 0.03% | 71 |
|
|
2025
Q1 | $612K | Buy |
16,900
+90
| +0.5% | +$3.26K | 0.02% | 74 |
|
|
2024
Q4 | $707K | Buy |
+16,810
| New | +$707K | 0.03% | 71 |
|
|
2024
Q3 | – | Sell |
-30,651
| Closed | -$1.26M | – | 122 |
|
|
2024
Q2 | $1.26M | Sell |
30,651
-102
| -0.3% | -$4.19K | 0.08% | 55 |
|
|
2024
Q1 | $1.44M | Buy |
+30,753
| New | +$1.44M | 0.09% | 59 |
|